Premium
Radiofrequency ablation of colorectal hepatic metastases
Author(s) -
Guenette Jeffrey P.,
Dupuy Damian E.
Publication year - 2010
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21658
Subject(s) - medicine , radiofrequency ablation , ablation , colorectal cancer , radiology , general surgery , oncology , cancer
Radiofrequency ablation (RFA) may be performed intraoperatively, laparoscopically, or percutaneously. The percutaneous approach is associated with the least procedural risk and may be performed under local anesthesia. Percutaneous RFA should be considered a primary treatment option for patients with unresectable hepatic tumors or conditions that prohibit general anesthesia or abdominal surgery. Continually improving thermal ablation and imaging technologies are likely to further increase tumor ablation efficacy and expand its role in treatment of hepatic metastases. J. Surg. Oncol. 2010;102:978–987. © 2010 Wiley‐Liss, Inc.